We added U251MG glioma cells with a simultaneous KD of the ACTC1 and ACTA2 genes as “ACTC1/ACTA2-KD cells” in vitro assays to explore the significance of this complementary regulation of ACTC1 and ACTA2 expression. This evidence concerns the gene ACTA2 and central nervous system cancer.